Showing results (3151-3160 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|May 21, 2008
Cost effectiveness of the German screen-and-treat strategy for postmenopausal osteoporosisDirk Mueller, Eva Weyler, Afschin GandjourPharmacoeconomics|January 1, 2017
Measuring Care-Related Quality of Life of Caregivers for Use in Economic Evaluations: CarerQol Tariffs for Australia, Germany, Sweden, UK, and USRenske J Hoefman, Job van Exel, Werner B F BrouwerPharmacoeconomics|March 8, 2006
Bimatoprost: a pharmacoeconomic review of its use in open-angle glaucoma and ocular hypertensionGreg L Plosker, Susan J KeamPharmacoeconomics|December 20, 2007
The last decade of Italian pharmaceutical policy: instability or consolidation?Giovanni Fattore, Claudio JommiPharmacoeconomics|December 20, 2007
Dynamic modelling of infectious diseases: an application to the economic evaluation of influenza vaccinationRoberto Pradas-Velasco, Fernando Antoñanzas-Villar, María Puy Martínez-ZáratePharmacoeconomics|December 20, 2007
Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational studyAlan F Cruess, Gergana Zlateva, Xiao Xu, et al.Pharmacoeconomics|January 19, 2006
Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in GermanyGerd Laux, Bart Heeg, Ben A van Hout, et al.Pharmacoeconomics|December 1, 2007
Economic evidence at the local level : options for making it more usefulKees van Gool, Gisselle Gallego, Marion Haas, et al.Pharmacoeconomics|October 11, 2016
Modeling Treatment Sequences in Pharmacoeconomic ModelsYing Zheng, Feng Pan, Sonja SorensenPharmacoeconomics|March 6, 2014
Methods for adjusting for bias due to crossover in oncology trialsK Jack Ishak, Irina Proskorovsky, Beata Korytowsky, et al.Pageof 336